Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADVANCED MEDICAL SOLUTIONS GROUP PLC AGM Information 2015

May 21, 2015

7467_agm-r_2015-05-21_839c8d4e-b702-4793-8a25-56e25ec81665.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8425N

Advanced Medical Solutions Grp PLC

21 May 2015

21 May 2015

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Annual General Meeting

Winsford, UK, 21 May 2015 - Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, will hold its Annual General Meeting at 11.00 a.m. today at 1 Cornhill, Gold Room, London, EC3V 3ND.

Chris Meredith, AMS's Chief Executive Officer, will give a short presentation at the Annual General Meeting.  No new material information will be provided.

AMS will be providing a trading update for the first half of the year later in June.

-     Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970
Gary Clarence / Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com 

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 470 employees.  For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOAPKKDBABKDAPB